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rates are accelerated in smokers.6 In this study multiple regression
analyses on a large population of patients found a positive
correlation of antipyrine clearance with smoking and age. Since
this study showed smoking capacity to decrease with age,
however, this shortening of antipyrine half life in smokers may
be partly due to age differences. Our study was designed to
overcome such defects.
Compounds present in cigarette smoke include 3, 4-
benzpyrene, 3-methylcholanthrene, and many related polycyclic
hydrocarbons."1 In-vivo animal studies and results from rat
fetal liver cell cultures26 have shown a direct inducing effect of
these hydrocarbons on the hepatic microsomal enzyme oxidising
systems. But in our study correlation of changes in antipyrine
half life with the number and type of cigarettes smoked and their
calculated nicotine and tar contents did not enable us to identify
the component of cigarette smoke responsible. This was largely
because nicotine levels and tar levels in cigarettes tend to
parallel each other thus making it difficult to discriminate
between these two components. Variability in the number of
puffs per cigarette and the extent of cigarette smoke inhalation
may also be important.
The mean increase of 230 of antipyrine half life on stopping
smoking is greater than the 12°% estimated by Vestal from
multiple regression analyses6; he also found that age contributed
30,, to interindividual variability while coffee and tea consump-
tion contributed less than 1(10. The mean decrease of antipyrine
half life was found to be 400 in insecticide workers,2 2200 in
those with a heavy alcohol intake,4 51 Go after 14 days'administra-
tion of the hypnotic glutethimide,'I and 340w after 140 mg
phenobarbital daily for two weeks.9 Since the 23°0 change in
cigarette smoking is comparable with these other well-known
inducing agents, we conclude that cigarette smoking is an
important factor contributing to the large variation in rates of
drug metabolism seen in man.
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hypnotherapy clinic; Professor B Halpern, University of Wollongong,
for performing the gas-liquid chromatography mass spectrometry
studies; Mrs Gail Williams for statistical advice; and the Australian
Tobacco Research Foundation for financial support. GCF is in receipt
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SHORT REPORTS
Computerised axial tomography
findings in patients with migrainous
headaches
The demonstration of cerebral oedema by computerised axial tomog-
raphy (CAT) in patients with migraine was drawn to our attention by
Drs J Ambrose and J Gawler of London. The subsequent unexpected
finding of a significant degree of cerebral atrophy in a migraine sufferer
further prompted our interest in the CAT changes in these patients.
The findings in 46 patients with migrainous headaches were therefore
reviewed.
Patients, methods, and results
Thirty women and 16 men with a history of recurrent migrainous headaches
for up to 18 years were examined on the EMI scanner, usually because of a
change in headache pattern.
The findings are summarised in the table. Small areas of infarction were
found in six cases. In four with fixed visual field defects these were in the
medial occipital cortex and were bilateral in two; in the other two small
clinically unsuspected areas of infarction were found in one temporal lobe.
Two patients without known intellectual dysfunction showed a significant
degree of cerebral atrophy. One was a 35-year-old woman who had had
classical migraine for several years, and the other was a 36-year-old woman
who had had mitral stenosis and intractable migrainous headaches for 10
months. Six other patients showed appearances suggestive of very early
cerebral atrophy. Twenty-one patients showed appearances compatible with
mild cerebral oedema-namely, increased blackening on the Polaroid
photograph and scattered matrix cells with ji values of two or more less than
contiguous cells. These appearances were most common in the frontal white
matter, being bilateral in 15, unilateral in four, and more extensive throughout
the hemisphere on the side of the headache and contralateral to the sensory
aura or signs, or both, in two (see table). Seven of these patients were scanned
during a migraine attack. Clinically unsuspected gliomas were found in two
patients, one with common migraine and one with a classical visual aura.
Focal neurological symptoms and signs in patients with normal and abnormal
CA Tfindings
CAT findings: Normal Infarcts Oedema Atrophy Tumour
No of patients .. 9 6 21 8 2
No with visual or other sensory i
aura ...4 6 2 1
No withfocal sigr's* 4 8 1 1
*Visual field defect or lateralised motor, sensory, or reflex changes.
Discussion
While the demonstration of areas of infarction in the visual cortex
in patients with fixed visual field defects was not unexpected, the
finding of small clinically silent areas of infarction in the temporal
lobe in two patients does suggest that focal cerebral damage due to
migrainous vasospasm may occur more often than is appreciated.
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Two possible explanations for the appearances of oedema need to
be considered. The first is that the low u numbers reflect an increased
fluid content of brain tissue-that is, true oedema-perhaps related to
regional cerebral ischaemia due to vasospasm or to arteriovenous
shunting with bypassing of the microcirculation.1 Alternatively, a
reduction in , numbers and increased blackening on the Polaroid film
might be due to a decreased content of blood per matrix cell if
regional cerebral blood flow were decreased at the time of scanning.
Further observations with both CAT and cerebral blood flow techni-
ques in the prodromal and headache phases of migraine are required
to throw further light on the significance of this finding.
The significance of the mild cerebral atrophy found in some patients
is uncertain. In view of the lack of data from normal volunteers,2 the
possibility that the mild widening of the subarachnoid space and
ventricular system in these patients may in fact represent one end of
the spectrum of normality rather than being truly indicative of early
cerebral atrophy cannot be excluded. Nevertheless, in view of the fact
that a greater degree of atrophy was found in two cases, it is tempting to
consider the possibility that some degree of cerebral atrophy may result
from the effects of recurrent episodes of regional cerebral ischaemia in
migraine.
We thank our radiological, neurological, and neurosurgical colleagues for
their co-operation.
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Pilonidal sinus of the prepuce
There have been many reports of pilonidal sinus at various sites since
the first description of a case in 1847 by Anderson. We report here a
case of pilonidal sinus of the prepuce, which has not previously been
recorded.
Case report
A single 40-year-old bottle packer presented to the casualty department on
28 June 1974 complaining of swelling and soreness of the penis. On examina-
tion he was a fit man of White race
with light brown hair. His penis was
grossly swollen, particularly around
the prepuce, so that it could not be
retracted. On 12 July his penis was
not painful, but there was some in-
duration of the skin on the left side of
the shaft. The prepuce was retracted
and three groups of hairs were seen
emerging from the inner surface of
the prepuce, just distal to its junction
with the shaft (see figure). One group
of hairs came out very easily. There
was no urethral discharge or lymph-
adenopathy.
He underwent circumcision on
23 September 1974, which showed
multiple sinuses just proximal to the
glans. The area of indurated tissue,
impregnated with hair, was excised
and the skin was closed with cat gut.
The macroscopic appearance of the
Hairs arising from inner surface hairs from the pilonidal sinus was
of prepuce. different from that of the rest of the
hairs on his pubic region. They were therefore sent for electron microscopy,
which showed them to be of human origin.
Discussion
Since Anderson first described pilonidal sinus, which commonly
occurs in the upper part of the natal cleft, there have been many
reports of similar pathology in other sites, including the supra-pubic
region, clitoris, upper eyelid, left brow, intermammary region,
cervical cutaneosubarachnoid region, ear, nipple, anal canal, scalp,
perineum, and mons pubis.
Pilonidal sinus of the shaft of the penis was described independently
by Bervar and Manojlovic1 and Yates-Bell" in 1968. Bervar and
Manojlovic in fact coined the name "pilonidal sinus penisa" for this
condition.
Since Patey and Scarff3 described pilonidal sinus of barber's hand
in 1946 the opinion has swung towards the view that it has an acquired
aetiology. Ghosh and Sanyal' emphasise this theory by stating that
pilonidal sinus is a peculiaritv of occupation and poor personal
hygiene; men are affected four times more than women, and the sub-
jects are usually hirsutes.
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We report the cases of three patients who after carbenoxolone treat-
ment developed weakness and areflexia mimicking a profound Guillain-
Barre syndrome.
Case reports
Case 1-A man aged 67 had reccived, unknown to us, carbenoxolone
150 mg daily for eight weeks. During the 10 days before his admission he had
noticed progressive weakness of his arms and legs, difficulty in swallowing,
and headaches and constipation. Examination showed a symmetrical proximal
weakness of the limbs with weak sternomastoids. Tendon reflexes were
diminished or absent. Sensation was normal. The provisional diagnosis was
Guillain-Barr& syndrome and he was treated with steroids. The cerebrospinal
fluid (CSF) protein was, however, normal, and the serum potassium con-
centration was 1-6 mmol (mEq) 1. ECG showed flat T and U waves. The
steroids were discontinued and he was given potassium supplements
80 mmol (mEq) day. After 48 hours he walked normally with a serum potas-
sium of only 2 1 mmol 1, and two weeks later his strength and serum potas-
sium level were normal.
Case 2-A 54-year-old mechanic was admitted to hospital unable to stand
after four weeks of progressive weakness and paracsthesiae of the limbs.
Inquiries showed that he had been taking carbenoxolone 300 mg daily. His
speech was slurred and he had weakness of the proximal arm and leg muscles
with distal paraesthesiae an I diminished reflexes. The CSF protein was raised
at 0 92 g9l with normal cells. Serum potassium was 1-6 mmol,l and he was
treated with oral and intravenous potassium. At 72 hours he was clinically
normal. Although he was receiving 100 mmol potassium daily, it took nine
days for his serum potassium to return to normal.
Case 3-A 50-year-old clerk was admitted to hospital after collapsing with a
suspected haemorrhage from a known gastric ulcer for which he was taking
carbenoxolone 150 mg daily. On admission he had weak muscles, paracsthe-
siae, and difficulty with speech, swallowing, and respiration. He required
intubation and assisted respiration for hypoventilatory hypoxaemia. His
